Valion Bio Advances Entolimod Into U.S.-Funded Efficacy Study
NIAID-RNCP selected Entolimod for a fully funded study evaluating efficacy against gastrointestinal acute radiation syndrome after positive safety findings.
NIAID-RNCP selected Entolimod for a fully funded study evaluating efficacy against gastrointestinal acute radiation syndrome after positive safety findings.